PDF Cover

Optical Coherence Tomography Systems Market

The market for Optical Coherence Tomography Systems was estimated at $2.6 billion in 2025; it is anticipated to increase to $4.9 billion by 2030, with projections indicating growth to around $9.0 billion by 2035.

Report ID:DS1801125
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Optical Coherence Tomography Systems
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Optical Coherence Tomography Systems Market Outlook

Revenue, 2025

$2.6B

Forecast, 2035

$9.0B

CAGR, 2026 - 2035

13.2%

The Optical Coherence Tomography Systems (OCT) industry revenue is expected to be around $2.6 billion in 2026 and expected to showcase growth with 13.2% CAGR between 2026 and 2035. Advanced medical imaging technologies such as optical coherence tomography technology are seeing rising demand. This demand is because of the growing need for clinical diagnostic techniques which are non invasive and have high resolution. It is also due to the increasing numbers of people suffering from chronic eye disease and cardiovascular disease. The majority, nearly 78%, of use is in ophthalmology and cardiology. This high level of adoption reflects the well established place that the optical coherence tomography technology has in the assessment of retinas, glaucoma and in imaging of coronary arteries. This imaging is used for the placement of stents and in identifying plaque. Fifteen years from now, FD OCT technologies will be generating revenue of nearly 1.8 billion dollars. This points to a strong preference from the market for imaging systems which use a fast and sensitive technique to provide clear images in real time from within catheter laboratories and other patient treatment region's. The demand for healthcare infrastructure, particularly diagnostic imaging, remains strong in both established and developing countries through the ongoing adoption of optical coherence tomography.

Using low coherence interferometry optical coherence tomography gives us a micrometer resolution 3D cross section of biological samples without having to damage them. The images produced can show details of microscopic structures in living organisms. Advanced optical coherence tomography technology now offers rapid image acquisition, improved depth penetration and image processing, which helps doctors accurately diagnose and treat eye conditions in various settings. Owing to features such as real time image rendering and integration with electronic patient records systems, OCT systems have been extensively used in the fields of dermatology, dentistry, ophthalmology and cardiology. This is in addition to their use in oncology. They also possess user interfaces which are very intuitive. The current trend in the market is for Optical Coherence Tomography architectures to hold sway, along with a rise in the use of catheter based and endoscopic configurations. There has also been the introduction of AI technology to enhance image analysis, and the increased use of portable and office Optical Coherence Tomography systems. These factors are contributing to a steady global demand for OCT.

Optical Coherence Tomography Systems market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Optical Coherence Tomography Systems Market Outlook

Market Key Insights

  • A predicted worth of $9 billion for the Optical Coherence Tomography Systems market by 2035 is seen with growth starting from $2.6 billion in 2025. The sector has experienced compound annual growth of 13.2 % with improvements in the Ophthalmology Diagnostics, Cardiac Imaging and Dermatology Diagnosis sectors.

  • This market is made up of players such as Carl Zeiss Meditec AG, Imalux Corp. and Heidelberg Engineering GmbH. These companies are in a position to influence the competitive market landscape.

  • The United States and Germany are major markets in the OCT sector, with these countries likely to achieve growth rates between 11.9 and 15.8% between 2025 and 2030.

  • The highest growth rates in the region are expected to be found in the emerging markets of India, South Africa and Brazil, at a compound annual growth rate of 9.2 to 13.9% .

  • The adoption of advanced imaging modalities like transition in the Optical Coherence Tomography Systems is predicted to contribute $549 million to the market size by the end of the year 2030.

  • Over the period 2025 to 2035 the Optical Coherence Tomography Systems market should be worth $6.4 billion. In this period those producing OCT systems which are used in the treatment of cardiovascular and oncology conditions are likely to gain share.

  • Due to a growing demand caused by a surge in ocular disease prevalence and improvements in healthcare technology, the market for optical coherence tomography systems will increase by approximately 246% over the period from 2025 to 2035.

optical coherence tomography systems market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Optical Coherence Tomography Systems - Country Share Analysis

Opportunities in the Optical Coherence Tomography Systems

Though commonly used in the investigation of arteries, optical coherence tomography systems for the interior of blood vessels are only occasionally used in those centres which undertake complex coronary interventions. Collaborative work could involve the stenting procedure optimisation and plaque characterisation in FD OCT and SEFD OCT from medical training institutions, device suppliers and hospital systems. The cardiovascular sector presently valued at $0.45 billion is also expected to see a rapid growth, reaching $0.96 billion by the year 2030. This represents the fastest CAGR at 16.45% and is the most rapidly growing of all cardiovascular imaging technology.

Growth Opportunities in North America and Asia-Pacific

Optical coherence tomography in North America is becoming distinct through its use in further cardiovascular studies. It helps to perform complex heart interventions and also coronary interventions through intravascular imaging with high resolution. Key growth opportunities exist for premium, feature rich cardiovascular devices OCT systems used in conjunction with cardiac cath labs, which come equipped with swept source and spectral domain technology. This combination enables faster imaging sessions and higher accuracy when placing stents. Established companies in the diagnostic imaging device market currently protect their share by means of a cardiology service bundle. Innovators, on the other hand, focus on development of catheters, miniaturised, that make use of optical coherent tomography, and AI for image analysis in order to capture market share in smaller sized hospitals. This regions greatest needs lie with the high incidence of cardiovascular disease, well established interventional cardiology facilities, and both favourable treatment and imaging costs. As well as a set of clinical standards which OCT is being measured against, in relation to the re opening of arteries, OCT is viewed as a major opportunity in cardiovascular applications here.
Throughout rapidly urbanising Asia Pacific, OCT is employed extensively for diagnosing a host of eye problems. The technologies are being used heavily in the diagnosis of myopia, diabetic retinopathy and glaucoma which are serious eye diseases. Opportunities for ophthalmic equipment OCT devices include portable, handheld versions to be used in remote or low resource region's, devices that can be used in large numbers in hospitals or clinics, and devices which couple OCT with other diagnostic techniques. As the global OCT business grows, manufacturers in countries such as South Korea, China and Japan are gaining a foothold, largely on the basis of competitive pricing and tailored after sales service. Manufacturers with a global reach, on the other hand, are establishing themselves as leaders through superior image quality. The key drivers of regional growth in the sector comprise government backed vision screening, expanding healthcare networks, rising affordability of eye care and an increasing awareness of early diagnosis. This positions ophthalmology focused OCT products as the leading investment opportunity in the Asia Pacific region.

Market Dynamics and Supply Chain

01

Driver: Technological Advancements in Healthcare

Advanced technologies in medicine have also long played a role in improving the way we diagnose and treat medical conditions effectively. One key technological advancement that stands out is also the creation of Optical Coherence Tomography Systems. These systems offer imaging and diagnostic capabilities that greatly enhance patient care. They play a role in identifying various conditions early onset stages especially in the field of ophthalmology where OCT technology has also become the preferred method, for analyzing retinal diseases. The increasing need, for less intrusive diagnostic methods is also pushing the OCT Systems market to new heights.
The rise of eye related issues such as macular degeneration glaucoma and diabetic retinopathy is also a growing concern as they impact a significant number of individuals globally The importance of efficient and timely detection methods like OCT cannot be overstated in addressing these conditions OCT systems have also revolutionized modern eye care by offering advanced imaging capabilities that allow for early diagnosis and prompt treatment of eye diseases This increasing demand is also driving rapid growth in the market, for OCT systems
02

Restraint: High Acquisition Costs

One of the obstacles to the expansion of Optical Coherence Tomography Systems in the market is their expensive price tags. These sophisticated medical imaging tools require a financial commitment from healthcare facilities. Smaller clinics and hospitals in areas may struggle to afford these systems due, to their high costs. As a result of the barrier posed by these expensive systems their utilization and dissemination might be restricted, thus impeding market growth prospects overall.
03

Opportunity: Emerging use of dermatology-focused OCT platforms for noninvasive skin cancer diagnostics in outpatient clinics and Rising demand for advanced ophthalmic imaging in diabetic retinopathy screening among aging global populations

Non invasive dermatological diagnostics are now a fast developing field. Optical coherence tomography devices will potentially help to reduce the number of dermatological patients who have to undergo biopsies. This also could assist in the early, accurate diagnosis of long term conditions. Compact TD OCT and medium range FD OCT devices are now being introduced at a faster rate into aesthetic centres, community dermatological clinics and outpatient clinics. Combining structural imaging with intuitive tools for reporting and reimbursement ready workflows will significantly boost the demand for dermatology focused optical coherence tomography. This is especially true in regions where there is a high incidence of skin cancer as well as in the developed world.
The increasing number of programmes for global screening of age related macular degeneration and diabetic retinopathy has led to a significant increase in the demand for optical coherence tomography systems. There is a vast untapped potential for using FD OCT devices in primary care centres for screening and vision care at the point of need especially for those living in deprived region's. The optical coherence tomography technology known as FD OCT is expected to reach $3.24 billion by the year 2030. It is expected to outstrip its rival technology, TD OCT, driven by improved resolution, faster imaging and software that streamlines processes.
04

Challenge: Inadequate Reimbursement Policies

A significant barrier to the growth of the OCT market is the reimbursement policies in place. In areas insurances do not only fully cover the high costs of procedures involving these systems. This disparity can dissuade patients from choosing OCT scans resulting in an impact on the demand for systems. The absence of insurance coverage presents a notable obstacle, to market growth.

Supply Chain Landscape

1

Component Sourcing

Carl Zeiss Meditec AGHeidelberg Engineering GmbH
2

System Manufacturing

Imalux Corp.Michelson Diagnostics
3

Integration Services

Novacam Technologies Inc.Carl Zeiss Meditec AG
4

Clinical Applications

Ophthalmology clinicshospitalsresearch institutes
Optical Coherence Tomography Systems - Supply Chain

Use Cases of Optical Coherence Tomography Systems in Ophthalmology Diagnostics & Dermatology Diagnosis

Ophthalmology Diagnostics : Optical Coherence Tomography Systems are mainly used in the field of ophthalmology to diagnose conditions effectively by producing detailed cross sectional images of the retina for detecting and managing diseases like glaucoma and macular holes, among others. The key players driving innovations in this sector include Zeiss, Leica and Nidek.
Cardiac Imaging : The OCT Devices are widely used in imaging to provide detailed micron scale resolution images for visualizing and measuring coronary microstructures that cannot be assessed through angiography or intravascular ultrasound . Leading companies in this market segment include Optovue and Heidelberg Engineering whore at the forefront of incorporating OCT technology, in cardiology applications.
Dermatology Diagnosis : In the field of dermatology OCT Systems play a role in guiding surgical biopsies and diagnosing different skin conditions like skin cancer. The benefits of OCT Systems such as their invasive nature, quick imaging capabilities and high resolution make them a valuable tool for this purpose. Leading companies, in this industry are Thorlabs and Michelson Diagnostics.

Recent Developments

Recent developments in optical coherence tomography (OCT) systems highlight strong momentum in AI integration, workflow automation, and enhanced imaging resolution. Companies like Carl Zeiss Meditec and Heidelberg Engineering are deploying AI‑enabled OCT platforms to improve retinal, glaucoma, and anterior segment diagnostics, boosting clinical efficiency. A key market trend is the shift toward high-throughput, non-invasive imaging with real-time analytics, enabling early disease detection and personalized ophthalmic care. Adoption is further accelerated by regulatory approvals, strategic partnerships, and expanded deployment in hospitals and specialty eye clinics worldwide.


July 2024 : EssilorLuxottica agreed to acquire an 80 % stake in Heidelberg Engineering, strengthening market reach and operational scale in OCT diagnostic imaging technology.
May 2024 : Carl Zeiss Meditec unveiled its CIRRUS 6000 OCT platform integrating AI‑enabled analytics and enhanced workflow support, advancing clinical efficiency and digital imaging performance.

Impact of Industry Transitions on the Optical Coherence Tomography Systems Market

As a core segment of the Medical Device industry, the Optical Coherence Tomography Systems market develops in line with broader industry shifts. Over recent years, transitions such as Transition to Advanced Imaging Modalities and Adoption of AI in Image Analysis have redefined priorities across the Medical Device sector, influencing how the Optical Coherence Tomography Systems market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Transition to Advanced Imaging Modalities

Advanced technologies in optical coherence tomography are changing the face of cardiology imaging and conventional ophthalmology imaging with the emergence of four dimensional OCT imaging and three dimensional OCT imaging. The introduction of new technologies is expected to drive significant expansion in the OCT sector, generating an extra $549 million by 2030. As demand for better clinical outcomes, superior diagnostic imaging and high resolution imaging grows, the businesses which are developing and integrating the latest imaging technology in their OCT will reap larger rewards. This consolidation of competitive advantage is helping to drive the growth of the global medical imaging industry, with increased clinical uptake and a shift in the long term market trend.
02

Adoption of AI in Image Analysis

With advancements in imaging technology, it is anticipated that AI will play an increasingly significant role in the analysis of the images produced by OCT. Currently advancements are being seen in the fields of neurology and dermatology. OCT systems are being developed with the AI element integrated in so as to produce better image quality and improve the OCT imaging process. With the aid of computers, trained to spot irregularities within OCT scans of the retina, doctors are able to diagnose eye conditions speedily, and promptly treat these conditions.